Deep Learning-Based Prediction of Protein Structure for Novel Antimicrobial Peptide Design

Authors

  • Schuster F Department of Bioinformatics, Charite University Medicine Berlin, Berlin, Germany Author
  • Renaud J Department of Computational Biology, Sorbonne University, Paris, France Author
  • Todorova R Department of Microbiology, Medical University of Sofia, Sofia, Bulgaria Author

DOI:

https://doi.org/10.5281/zenodo.22638268

Keywords:

antimicrobial peptides, deep learning, protein structure prediction, generative models, antimicrobial resistance

Abstract

Background: Rising antimicrobial resistance has renewed interest in antimicrobial peptides (AMPs) as anti-infective candidates,
but rational design remains constrained by limited structural insight. Objective: This narrative review synthesizes published
literature on how deep learning-based structure prediction and generative sequence design are being applied to novel AMP
discovery. Methods: We examine peer-reviewed studies on structure predictors (AlphaFold, RoseTTAFold, ESMFold), generative
diffusion and sequence-design tools (RFdiffusion, ProteinMPNN), deep generative AMP models (HydrAMP, AMPGAN v2), and
large-scale machine-learning mining pipelines validated against curated databases (APD3, DBAASP, DRAMP). Findings: Structure
predictors offer rapid but variably accurate models for short, often disordered peptides, while generative and mining pipelines
have produced experimentally validated hits, including hundreds of thousands of computationally proposed candidates yielding
dozens to hundreds of confirmed active peptides across independent studies. Conclusions: Deep learning has substantially
accelerated AMP candidate generation and prioritization, but heterogeneous training data, peptide-scale structural uncertainty,
and unresolved toxicity prediction remain key barriers to clinical translation.

References

Murray CJL, Ikuta KS, Sharara F, et al. (2022). Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. The Lancet, 399(10325), 629-655. DOI: 10.1016/S0140-6736(21)02724-0.

Fjell CD, Hiss JA, Hancock REW, Schneider G (2012). Designing antimicrobial peptides: form follows function. Nature Reviews Drug Discovery, 11, 37-51. DOI: 10.1038/nrd3591.

Jumper J, Evans R, Pritzel A, et al. (2021). Highly accurate protein structure prediction with AlphaFold. Nature, 596(7873), 583-589. DOI: 10.1038/s41586-021-03819-2.

Baek M, DiMaio F, Anishchenko I, et al. (2021). Accurate prediction of protein structures and interactions using a three-track neural network. Science, 373(6557), 871-876. DOI: 10.1126/science.abj8754.

Lin Z, Akin H, Rao R, et al. (2023). Evolutionary-scale prediction of atomic-level protein structure with a language model. Science, 379(6637), 1123-1130. DOI: 10.1126/science.ade2574.

Wang G, Li X, Wang Z (2016). APD3: the antimicrobial peptide database as a tool for research and education. Nucleic Acids Research, 44(D1), D1087-D1093. DOI: 10.1093/nar/gkv1278.

Pirtskhalava M, Amstrong AA, Grigolava M, et al. (2021). DBAASP v3: database of antimicrobial/cytotoxic activity and structure of peptides as a resource for development of new therapeutics. Nucleic Acids Research, 49(D1), D288-D297. DOI: 10.1093/nar/gkaa991.

Shi G, Kang X, Dong F, et al. (2022). DRAMP 3.0: an enhanced comprehensive data repository of antimicrobial peptides. Nucleic Acids Research, 50(D1), D488-D496. DOI: 10.1093/nar/gkab651.

Evans R, O'Neill M, Pritzel A, et al. (2021). Protein complex prediction with AlphaFold-Multimer. bioRxiv. DOI:

1101/2021.10.04.463034. 10. Gulsevin A, Meiler J (2023). Benchmarking AlphaFold2 on peptide structure prediction. Structure, 31(1), 111-119.e2. DOI: 10.1016/j.str.2022.11.012.

Watson JL, Juergens D, Bennett NR, et al. (2023). De novo design of protein structure and function with RFdiffusion. Nature, 620(7976), 1089-1100. DOI: 10.1038/s41586-023-06415-8.

Dauparas J, Anishchenko I, Bennett N, et al. (2022). Robust deep learning-based protein sequence design using ProteinMPNN. Science, 378(6615), 49-56. DOI: 10.1126/science.add2187.

Szymczak P, Możejko M, Grzegorzek T, et al. (2023). Discovering highly potent antimicrobial peptides with deep generative model HydrAMP. Nature Communications, 14, 1453. DOI: 10.1038/s41467-023-36994-z.

Van Oort CM, Ferrell JB, Remington JM, Wshah S, Li J (2021). AMPGAN v2: Machine Learning-Guided Design of Antimicrobial Peptides. Journal of Chemical Information and Modeling, 61(5), 2198-2207. DOI: 10.1021/acs.jcim.0c01441.

Liu Y, et al. (2025). A Multi-Property Optimizing Generative Adversarial Network for de novo Antimicrobial Peptide Design. Advanced Science, 12. DOI: 10.1002/advs.202503443.

Grisoni F, Neuhaus CS, Gabernet G, Müller AT, Hiss JA, Schneider G (2018). Designing anticancer peptides by constructive machine learning. ChemMedChem, 13(13), 1300-1302. DOI: 10.1002/cmdc.201800204.

Veltri D, Kamath U, Shehu A (2018). Deep learning improves antimicrobial peptide recognition. Bioinformatics, 34(16), 2740-2747. DOI: 10.1093/bioinformatics/bty179.

Capecchi A, Cai X, Personne H, Köhler T, van Delden C, Reymond JL (2021). Machine learning designs non-hemolytic antimicrobial peptides. Chemical Science, 12(26), 9221-9232. DOI: 10.1039/D1SC01713F.

Wang B, Lin P, Zhong Y, et al. (2025). Explainable deep learning and virtual evolution identifies antimicrobial peptides with activity against multidrug-resistant human pathogens. Nature Microbiology, 10(2), 332-347. DOI: 10.1038/s41564-024-01907-3.

Ma Y, Guo Z, Xia B, et al. (2022). Identification of antimicrobial peptides from the human gut microbiome using deep learning. Nature Biotechnology, 40, 921-931. 10.1038/s41587-022-01226-0.

Huang J, Xu Y, Xue Y, et al. (2023). Identification of potent antimicrobial peptides via a machine-learning pipeline that mines the entire space of peptide sequences. Nature Biomedical Engineering, 7(6), 797-810. 10.1038/s41551-022-00991-2.

Santos-Júnior CD, Torres MDT, Duan Y, et al. (2024). Discovery of antimicrobial peptides in the global microbiome with machine learning. Cell, 187(14). 10.1016/j.cell.2024.05.013.

Wan F, Torres MDT, Peng J, de la Fuente-Nunez C (2024). Deep-learning-enabled antibiotic discovery through molecular de-extinction. Nature Biomedical Engineering, 8(7), 854-871. DOI: 10.1038/s41551-024-01201-x.

Stokes JM, Yang K, Swanson K, et al. (2020). A Deep Learning Approach to Antibiotic Discovery. Cell, 180(4), 688-702.e13. DOI: 10.1016/j.cell.2020.01.021.

Pandi A, Adam D, Zare A, et al. (2023). Cell-free biosynthesis combined with deep learning accelerates novo-development of antimicrobial peptides. Nature Communications, 14, 7197. DOI: 10.1038/s41467-023-42434-9.

Wan F, Wong F, Collins JJ, de la Fuente-Nunez C (2024). Machine learning for antimicrobial peptide identification and design. Nature Reviews Bioengineering, 2(5), 392-407. DOI: 10.1038/s44222-024-00152-x.

Yang KK, Wu Z, Arnold FH (2019). Machine-learning-guided directed evolution for protein engineering. Nature Methods, 16, 687-694. DOI: 10.1038/s41592-019-0496-6. DOI: DOI: DOI: de

Downloads

Published

2026-06-27